1. Treatment of rheumatoid arthritis with conventional, targeted and biological disease-modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease

   • Tatjana Zekić
   • Mirjana Stanić Benić
   • Mislav Radić

   Review 23 May 2022 Pages: 1665 - 1679

   

2. Effectiveness of aquatic exercise in the treatment of inflammatory arthritis: systematic review

   • Larissa Nakahata Medrado
   • Maria Lua Marques Mendonça
   • Paula Felippe Martinez

   Systematic Review 28 May 2022 Pages: 1681 - 1691

   

3. Correlates of physical activity in adults with spondyloarthritis and rheumatoid arthritis: a systematic review

   • Thomas Ingram
   • Raj Sengupta
   • Peter Rouse

   Systematic Review Open access 08 June 2022 Pages: 1693 - 1713

   

4. Systemic lupus erythematosus, a leading cause of death in young Mexican females: a nationwide population-based study, 2000–2020

   • Ivet Etchegaray-Morales
   • Claudia Mendoza-Pinto
   • Mario García-Carrasco

   Public Health 08 June 2022 Pages: 1715 - 1720

5. Incidence of giant cell arteritis in six districts of Paris, France (2015–2017)

   • Solange Gonzalez Chiappe
   • Sarah Lechtman
   • Alfred Daniel Mahr

   Epidemiology of RMD 12 July 2022 Pages: 1721 - 1728

   

6. Spondyloarthritis in familial Mediterranean fever: a cohort study

   • Sevtap Acer Kasman
   • Mehmet Tuncay Duruöz

   Cohort Studies 18 June 2022 Pages: 1729 - 1739

   

7. Higher antibody responses after mRNA-based vaccine compared to inactivated vaccine against SARS-CoV-2 in Behcet’s syndrome

   • Ayse Ozdede
   • Okan Kadir Nohut
   • Emire Seyahi

   Observational Research 02 July 2022 Pages: 1741 - 1750

   

8. Clinical characteristics of patients with spondyloarthritis and inflammatory bowel disease versus inflammatory bowel disease-related arthritis

   • Keisuke Ono
   • Mitsumasa Kishimoto
   • Shinya Kaname

   Observational Research 09 May 2022 Pages: 1751 - 1766

   

9. Prevalence of ECG testing and characteristics among new hydroxychloroquine and chloroquine users within a multi-center tertiary care center

   • May Y. Choi
   • Brittany Weber
   • Karen H. Costenbader

   Observational Research 16 April 2022 Pages: 1767 - 1774

10. Quality of life and disease activity of patients with rheumatoid arthritis on tofacitinib and biologic disease-modifying antirheumatic drug therapies

    • Vladimira Boyadzhieva
    • Konstantin Tachkov
    • Guenka Petrova

    Observational Research 27 June 2022 Pages: 1775 - 1783

11. Development and validation of a self-administered questionnaire measuring essential knowledge in patients with rheumatoid arthritis

    • Malory Rodère
    • Bruno Pereira
    • Catherine Beauvais

    Observational Research Open access 07 April 2022 Pages: 1785 - 1795

    

12. Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?

    • Ufuk İlgen
    • Ömer Karadağ
    • Umut Kalyoncu

    Observational Research 29 April 2022 Pages: 1797 - 1806

    

13. Patients’ and clinicians’ perspectives on the clinical utility of the Rheumatoid Arthritis Foot Disease Activity Index

    • Anika Hoque
    • Martijn Steultjens
    • Gordon J. Hendry

    Observational research Open access 27 May 2022 Pages: 1807 - 1817

    

14. Impact of rheumatoid arthritis on sexuality: adaptation and validation of the Qualisex questionnaire for use in Spain

    • Montserrat Romera Baures
    • Daniel Seoane-Mato
    • The Adaptación-Qualisex Study Group

    Validation Studies 16 November 2021 Pages: 1819 - 1829

    

15. Patient perspectives on the British Columbia Biosimilars Initiative: a qualitative descriptive study

    • Caitlin Chew
    • Magda Aguiar
    • Mark Harrison

    Patient Opinion Open access 07 May 2021 Pages: 1831 - 1842

    

16. Rituximab therapy in pericarditis associated with rheumatoid arthritis

    • Ali Taylan

    Case Based Review 05 January 2022 Pages: 1843 - 1847

    

17. Methotrexate induced neurotoxicity in a patient with rheumatoid arthritis on rituximab therapy: a case-based review

    • Nikolaos Kougkas
    • Athanasia Dara
    • Theodoros Dimitroulas

    Case Based Review 18 July 2022 Pages: 1849 - 1854

    

18. Vision loss in giant cell arteritis: case-based review

    • Ioanna Nefeli Kokloni
    • Souzana Ioanna Aligianni
    • Dimitrios Daoussis

    Case Based Review 21 June 2022 Pages: 1855 - 1862

    

19. ANCA-associated vasculitis with protein-losing enteropathy is characterized by hypocomplementemia

    • Manaka Goto
    • Yumi Tsuchida
    • Keishi Fujio

    Case Based Review 22 June 2021 Pages: 1863 - 1872

    

20. Ankylosing spondylitis on unidentified individual from early modern times found in reformed church (Silická Brezová, Slovakia): a case-based review

    • Jana Gaľová
    • Soňa Tökölyová
    • Iveta Boroňová

    Case Based Review 07 June 2022 Pages: 1873 - 1881